Dr. Metrock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 7th Avenue S
Lowder 500
Birmingham, AL 35233
Education & Training
- Emory University School of MedicineFellowship, Pediatric Neuro-Oncology, 2016 - 2017
- Emory UniversityCertificate, Translational Research, 2016 - 2017
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- Emory University School of MedicineResidency, Pediatrics, 2010 - 2013
- Medical College of Georgia at Augusta UniversityClass of 2010
Certifications & Licensure
- AL State Medical License 2018 - 2024
- GA State Medical License 2013 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase II Trial of Poly-ICLC for Low-Grade Gliomas Start of enrollment: 2021 Dec 15
Roles: Contact
Publications & Presentations
PubMed
- 6 citationsPediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.Amar Gajjar, Anita Mahajan, Mohamed Abdelbaki, Clarke Anderson, Reuben Antony
Journal of the National Comprehensive Cancer Network. 2022-12-01 - 49 citationsAn Update on Neurofibromatosis Type 1-Associated GliomasMina Lobbous, Joshua D. Bernstock, Elizabeth Coffee, Gregory K. Friedman, Laura K. Metrock
Cancers. 2020-01-01 - 48 citationsPediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition.Gourish Mondal, Julieann C. Lee, Ajay Ravindranathan, Javier Villanueva-Meyer, Quynh T. Tran
Acta Neuropathologica. 2020-04-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: